HMB Free Acid (myHMB).

Free acid HMB and calcium HMB deliver the identical metabolite, differing in how quickly plasma levels rise rather than in what arrives. Listing both stacks one compound rather than adding a second.

Roughly five percent of dietary leucine is converted to HMB by way of ketoisocaproate, so the two sit on one pathway. Leucine also signals mTOR directly, which HMB does only weakly, so the roles differ.

Leucine is the upstream amino acid from which HMB is formed, and the conversion rate is low enough that direct HMB gives far higher levels than leucine alone. The two are complementary rather than interchangeable.

Valine competes with leucine for the same transporter and aminotransferase, so branched-chain ratios shape how much leucine is available for HMB formation. Formulas that carry HMB usually hold the branched-chain profile alongside it.

Creatine raises phosphocreatine availability for short bursts of work while HMB acts on protein turnover and membrane cholesterol synthesis in muscle. Neither competes for the other's pathway, which is why they appear together.

Creatine supports the immediate energy system while HMB acts on the balance between muscle protein synthesis and breakdown. The two occupy separate points in the training response.

Skeletal muscle carries vitamin D receptors and adequate vitamin D status is associated with normal muscle fibre function and protein synthesis signalling. HMB acts on the turnover side, so the pair is routinely built together for older adults.

Vitamin D status shapes how muscle responds to a protein or anabolic signal, while HMB acts on the breakdown side of the balance. Formulas for maintaining lean mass in older adults commonly carry both.

Glutamine is the most abundant intracellular amino acid in muscle and supports nitrogen transport and cell volume, a separate axis from the turnover signalling HMB affects. The two have been formulated together in recovery stacks for decades.

Arginine supplies nitric oxide substrate and contributes to nitrogen balance, and it has been paired with HMB and glutamine in lean mass formulas since the 1990s. The mechanisms are separate rather than overlapping.

Branched-chain aminotransferase converts leucine to alpha-ketoisocaproate using pyridoxal 5-phosphate as its cofactor, and that ketoacid is the direct precursor of HMB in the body. Adequate B6 is therefore a condition of endogenous HMB production. Supplemental HMB bypasses that step entirely, which is part of why it is taken as a finished metabolite.

Alpha-ketoisocaproate can go down the main mitochondrial route, where methylcrotonyl-CoA carboxylase requires biotin, or down the minor cytosolic route that yields HMB. The two branches draw on the same substrate. That makes biotin status a determinant of how leucine is partitioned rather than an enhancer of supplemental HMB.

Whey supplies leucine, only a small fraction of which is converted to HMB endogenously, so a supplemental dose of the metabolite delivers far more of it than protein intake does. The two are typically taken together in the same formula for that reason. They act on overlapping signalling, so the combined effect should not be assumed to add up.

HMB's described actions are on the signalling and breakdown side; building tissue still requires amino acid substrate to be present. A slowly digested protein keeps that substrate available over a longer window. The pairing is a formulation rationale, not a measured combined result.

Beta-alanine raises muscle carnosine and works on hydrogen ion buffering during high-intensity effort, while HMB acts on protein turnover during recovery. The two address different constraints in the same training programme. Combining them is a programme design decision, not a chemical interaction.

Taurine is a muscle osmolyte and antioxidant with no shared pathway with HMB. Products pair them for breadth rather than for a described interaction. The row records the co-formulation and its lack of a mechanistic basis.

Citrulline escapes the first-pass metabolism that limits oral arginine and raises plasma arginine more effectively, which supports nitric oxide production and muscle perfusion. Better perfusion means better delivery of the substrate that HMB signalling acts on. The link is indirect and has not been measured as a pair.

Collagen peptides supply glycine, proline and hydroxyproline for connective tissue, which is not the pool HMB signalling addresses. Formulas combine them to cover both. This is complementary coverage, not synergy.

Every ATP-dependent step of protein synthesis uses magnesium-bound ATP, so magnesium status is a background condition for the process HMB is aimed at. That makes it permissive rather than synergistic. The relationship is generic to protein synthesis and not specific to HMB.

Zinc finger transcription factors and numerous synthetic enzymes depend on zinc availability, which places it upstream of any anabolic signalling. That makes it a permissive nutrient rather than a partner with a specific mechanism. Stated so the pairing is not read as a targeted synergy.

Calcium HMB monohydrate delivers calcium alongside the metabolite, while the free acid does not. A formula stacking calcium HMB with a separate calcium ingredient should count both contributions. This is dose accounting, not an interaction.